| [1] | Wang Fang, Quan ZuoHua, Yang XingKun, Kou JunFeng, Yun ShengHao, Cai GuoFang, Zhou XinRen. Influence of antiviral therapy with telbivudine on serum soluble complement receptor type 1 in patients with chronic hepatitis B or liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1118-1120. doi: 10.3969/j.issn.1001-5256.2016.06.019 |
| [2] | Wang RongQi, Nan YueMin. Neutropenia caused by telbivudine in chronic hepatitis B patients: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(2): 273-274. doi: 10.3969/j.issn.1001-5256.2015.02.031 |
| [3] | Chen Zhi, Zhu HaiHong, Yang Ying. Cytokine storm and liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 981-983. doi: 10.3969/j.issn.1001-5256.2014.10.003 |
| [4] | Huang HongFei, He DengMing, Wu QuanXin, Li MaoShi, Zhu Peng, Wang YuMing. Changes in serum levels of Th1 /Th2 cytokines in HBeAg- positive pregnant women with HBV infection after telbivudine treatment[J]. Journal of Clinical Hepatology, 2014, 30(6): 522-526. doi: 10.3969/j.issn.1001-5256.2014.06.011 |
| [5] | Jiang XiuNong, Fan LingYan, Li DeZhou, Wan Jiong, Ye JingJing. Clinical trial of telbivudine in the treatment of chronic hepatitis B in patients during the third trimester of pregnancy[J]. Journal of Clinical Hepatology, 2013, 29(2): 101-103. |
| [6] | Guo RuYi, Yu XuePing, Su ZhiJun, Lin ChengZu, Lin ZhiPeng, Lin Qi. Evaluation of telbivudine’s efficacy for treating HBeAg-positive chronic B hepatitis patients and identification of its predictive factors by logistic regression analysis[J]. Journal of Clinical Hepatology, 2013, 29(2): 97-100. |
| [7] | Xie Rong, Jiang JianNing, Su MingHua, Liu ZhiHong, Zhong ShaoHua, He LiXia, Liang YanXiu, Hu JiaGuang, Huang XiaoHong, Guo WenWen, Fu WuDao, Zhu MeiQin, Wang BaoJian. Efficacy and safety of initial telbivudine treatment in chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(6): 422-424+427. |
| [8] | Wang HaiYan, Wang Yu, Peng XiaoMing, Liu Ya. Recent advancement of telbivudine in the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(12): 1320-1322+1326. |
| [9] | Zhan GuoQing, Tan HuaBing, Zhang WeiWei, Li RuGui, Xie XingRong, Hu Bo. The factors predicting the efficacy of telbivudine in the treatment of HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2011, 27(6): 608-610. |
| [10] | Jin QingLong, Wang ZhongFeng, Yan HongQing, Niu JunQi. The study of the change in creatine kinase in patients with chronic hepatitis B during the antiviral treatment with Telbivudine and Lamivudine[J]. Journal of Clinical Hepatology, 2011, 27(2): 143-144+156. |
| [11] | Luo FangQiong, Pan Yu, Liu JingJing, Zhang Peng, Niu JunQi, Jiang YanFang. The Impact of Adefovior dipivoxil on Th1/Th2 cytokines in chronic hepatitis B Patients[J]. Journal of Clinical Hepatology, 2010, 26(1): 19-21. |
| [13] | Li Zhi, Yan HongMei, Xue FaXuan, Wang Tong, Liang Qun, Xu Huan, Li ZhangChun. Short-term clinical effect of telbivudine in the treatment chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(6): 420-421+426. |
| [14] | Wang Chong, Jiang YanFang, Jin QingLong, Bao WanGuo, Wang Feng, Niu JunQi. The detection of cytokines IFN-γ、TNF-α、IL-4、IL-10 in the serum of patients of liver disease[J]. Journal of Clinical Hepatology, 2009, 25(2): 99-101. |
| [15] | Huang ZhongFa, Zhu Qing, Fu QiMei, Bu QuanHui, Shi BinBin. The effect of Interferon treatment on cellular immuneresponses in patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(5): 326-328. |
| [18] | Zhang Biao, Sui Tao, Yu XiuYing, Cao YongXian, Yao Yuan, He Hong. Significance of detecting apoptosis of PBMC and cytokine of supernatant induced by PHA in chronic hepatitis B[J]. Journal of Clinical Hepatology, 2004, 20(3): 138-140. |
| [20] | Zhu XinYu, Wang QinYing, Wang ShouYi. A Study on correlation of cytokine and the chronicity of hepatitis B[J]. Journal of Clinical Hepatology, 2003, 19(4): 217-219. |
DownLoad: